PHARMACEUTICAL DOSAGE FROM OF PSEUDOEPHEDRINE AND LORATADINE FOR TWICE-A-DAY ADMINISTRATION

摘要

Pharmaceutical dosage from of pseudoephedrine and loratadine for twice-a-day administration comprising an extended release core of pseudoephedrine and immediate release coating layer of loratadine and pseudoephedrine is disclosed. It also discloses dosage forms providing an in vitro release profile of pseudoephedrine, which is pH independent and devoid of any lag phase.